<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[E-Z-EM Inc. | Company News & Executive Profiles - EZEM | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/e-z-em+inc..html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for E-Z-EM Inc.]]></description>
	<s:counts start="0" returned="10" found="12" />
	<language>en-us</language>
	<item>
		<title><![CDATA[E-Z-EM Inc. Expands Manufacturing Capacity for Its RSDL&#153; Skin Decontaminants]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_17/ai_n19521625]]></link>
		<description><![CDATA[LAKE SUCCESS, N.Y. -- E-Z-EM Inc. (Nasdaq:EZEM) announced today that it has completed a multi-million dollar expansion of its Canadian manufacturing facility used for the production of RSDLTM decontamination lotion. Located at E-Z-EM's current Good Manufacturing Practices cGMP pharmaceutical facility in Montreal, Canada, the expansion provides a significant increase in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/canada.html"><![CDATA[Canada]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/imaging.html"><![CDATA[imaging]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/procurement.html"><![CDATA[procurement]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+defense.html"><![CDATA[U.S. Department of Defense]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
	<item>
		<title><![CDATA[E-Z-EM Launches www.RSDecon.com Site for RSDL]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_April_27/ai_n26842146]]></link>
		<description><![CDATA[LAKE SUCCESS, N.Y. -- E-Z-EM, Inc. (NASDAQ:EZEM) today announced the launch of www.RSDecon.com, a new website dedicated to the Company's Reactive Skin Decontamination Lotion (RSDLTM) product. The Company developed the site to provide an informative resource for the military and emergency first responder personnel who make up the two primary...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Apr 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+defense.html"><![CDATA[U.S. Department of Defense]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
	<item>
		<title><![CDATA[Parent Firm to Spin Off Queensbury, N.Y., Medical Device Maker AngioDynamics.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200403/ai_n22129511]]></link>
		<description><![CDATA[By Kevin Harlin, Times Union, Albany, N.Y. Knight Ridder/Tribune  Business News    Mar. 9--The parent of AngioDynamics Inc. will spin off the  Queensbury  medical device maker with an initial public offering of  stock that is expected  to raise $30.6 million.   ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 09 Mar 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/albany.html"><![CDATA[Albany]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/ipo.html"><![CDATA[IPO]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">ANGO,EZEM</category>
	</item>
	<item>
		<title><![CDATA[U.S. Army testing E-Z-EM chemical warfare lotion]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4189/is_20031128/ai_n10168226]]></link>
		<description><![CDATA[E-Z-EM Inc. (AMEX: EZM) said Monday the U.S. Army has signed a contract for the final testing of a skin decontamination lotion that it manufactures.   E-Z-EM produces the Reactive Skin Decontamination Lotion for Cambridge, Ontario-based O'Dell Engineering Ltd.   The Army will buy limited quantities of the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 28 Nov 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+army.html"><![CDATA[U.S. Army]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
	<item>
		<title><![CDATA[Four new tenants sign lease at i.park site]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4189/is_20020802/ai_n10165588]]></link>
		<description><![CDATA[The New York Mercantile Exchange leads the list of four new tenants taking space at i.park, which is attracting significant interest despite current economic woes.    The NYMEX has signed to lease 40,000 square feet of space at the former Sperry and Lockheed Martin facility that once served...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 02 Aug 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nymex.html"><![CDATA[Nymex]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
	<item>
		<title><![CDATA[E-Z-EM, Inc. Corrects Factors' Impact on Earnings; $418,000, or $.04 per basic share Sted $337,000, or $.03 per basic share]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Oct_12/ai_66008768]]></link>
		<description><![CDATA[Health/Medical Editors  CORRECTION...by E-Z-EM, Inc.  --BUSINESS WIRE  In BW2556, (NY-E-Z-EM) reports financial results, third graph, second line should read $418,000, or $.04 per basic share (sted $337,000, or $.03 per basic share).]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Oct 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/business+wire.html"><![CDATA[Business Wire]]></category>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
	<item>
		<title><![CDATA[E-Z-EM, Inc., Announces Preliminary Results for First Quarter Fiscal 2000]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_Sept_30/ai_55926939]]></link>
		<description><![CDATA[WESTBURY, N.Y.--BUSINESS WIRE--Sept. 30, 1999--]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 30 Sep 1999 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/westbury+plc..html"><![CDATA[Westbury Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+wire.html"><![CDATA[Business Wire]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
	<item>
		<title><![CDATA[E-Z-EM Inc. Proceeding With Plans To Market New MRI Contrast Agent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1997_Jan_7/ai_18997054]]></link>
		<description><![CDATA[WESTBURY, N.Y.--HealthWire--Jan. 7, 1997--    Approvable Letter From FDA On New Drug Application Received By Manufacturer of GADOLITER Oral Suspension    E-Z-EM Inc. (AMEX: EZM.A and EZM.B) today announced that Pharmacyclics Inc., the manufacturer of GADOLITER Oral Suspension, has received a letter from the Food and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 07 Jan 1997 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/westbury+plc..html"><![CDATA[Westbury Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
	<item>
		<title><![CDATA[E-Z-EM Inc. introduces contrast agent for new "see-through" small bowel radiographic study; Entero Vu&#153; provides detailed images not possible with conventional small bowel x-ray examination]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1996_Sept_5/ai_18651176]]></link>
		<description><![CDATA[WESTBURY, N.Y.--HealthWire--Sept. 5, 1996--A new procedure for imaging the small bowel was introduced today by E-Z-EM Inc. (AMEX:EZMA and EZMB).Referred to as a "see-through" small bowel radiographic study, the procedure employs E-Z-EM's newly developed contrast agent marketed under the name Entero VuTM.Archie Williams, E-Z-EM's Vice President of Imaging Products describes...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 05 Sep 1996 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/westbury+plc..html"><![CDATA[Westbury Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
	<item>
		<title><![CDATA[E-Z-EM, Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m3498/is_n3_v59/ai_18191948]]></link>
		<description><![CDATA[E-Z-EM, Inc., Westbury, N.Y., says its AngioDynamics division kicked off its initial offshore sales of [CO.sub.2]ject[TM], a new system for angiographic procedures that uses carbon dioxide contrast agents instead of the more costly iodinated media used in most of today's procedures. [CO.sub.2]ject has been cleared for sale in Australia, Spain...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Mar 1996 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/e-z-em+inc..html"><![CDATA[E-Z-EM Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/westbury+plc..html"><![CDATA[Westbury Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EZEM</category>
		<category domain="tickers">EZEM</category>
	</item>
</channel>
</rss>
